Mining bacterial genomes for novel antimicrobials by Sharp, C

Host control and the evolution of cooperation in host microbiomes by Sharp, C, Foster, KR

Study of UK men who had participated in the UK nuclear weapons test programme. by Doll, R, Sharp, C, Muirhead, C, Darby, S

Human parvovirus 4 'PARV4' remains elusive despite a decade of study by Matthews, P, Sharp, C, Simmonds, P, Klenerman, P

Bacterial competition systems share a domain required for inner membrane transport of the bacteriocin pyocin G from Pseudomonas aeruginosa by Atanaskovic, I, Sharp, C, Press, P, Kaminska, R, Kleanthous, K

Diversity and distribution of nuclease bacteriocins in bacterial genomes revealed using Hidden Markov Models by Sharp, C, Bray, J, Housden, N, Maiden, M, Kleanthous, C

Parametric analysis of an efficient boundary condition to control outlet flow rates in large arterial networks by Sharp C. Y. Lo, Jon W. S. McCullough, Peter V. Coveney

Get full text

The great divide: an analysis of housing inequality by Dorling, D, Ford, J, Holmans, A, Sharp, C, Thomas, B, Wilcox, S

PARV4: an emerging tetraparvovirus by Matthews, P, Malik, A, Simmons, R, Sharp, C, Simmonds, P, Klenerman, P

Evolution of CD8+ T cell responses after acute PARV4 infection. by Simmons, R, Sharp, C, Levine, J, Bowness, P, Simmonds, P, Cox, A, Klenerman, P

Targeted killing of pseudomonas aeruginosa by Pyocin G occurs via the Hemin Transporter Hur by Atanaskovic, I, Mosbahi, K, Sharp, C, Housden, NG, Kaminska, R, Walker, D, Kleanthous, C

High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo by Simmons, R, Sharp, C, Sims, S, Kloverpris, H, Goulder, P, Simmonds, P, Bowness, P, Klenerman, P

High frequency, sustained T cell responses to PARV4 by Simmons, R, Sharp, C, Sims, S, Kloverpris, H, Goulder, P, Simmonds, P, Bowness, P, Klenerman, P

O-antigen dependent colicin insensitivity of uropathogenic Escherichia coli by Sharp, C, Boinett, C, Cain, A, Housden, N, Kumar, S, Turner, K, Parkhill, J, Kleanthous, C

High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. by Simmons, R, Sharp, C, Sims, S, Kloverpris, H, Goulder, P, Simmonds, P, Bowness, P, Klenerman, P

Methodological considerations in measurement of the P300 component of the auditory oddball ERP in schizophrenia. by Glabus, M, Blackwood, D, Ebmeier, K, Souza, V, Walker, M, Sharp, C, Dunan, J, Muir, W

Human parvovirus 4 infection, Cameroon. by Lavoie, M, Sharp, C, Pépin, J, Pennington, C, Foupouapouognigni, Y, Pybus, O, Njouom, R, Simmonds, P

High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies. by Sharp, C, Lail, A, Donfield, S, Simmons, R, Leen, C, Klenerman, P, Delwart, E, Gomperts, E, Simmonds, P

Redefining the overtraining syndrome as the unexplained underperformance syndrome. by Budgett, R, Newsholme, E, Lehmann, M, Sharp, C, Jones, D, Peto, T, Collins, D, Nerurkar, R, White, P

Human parvovirus 4 infection among mothers and children in South Africa by Matthews, P, Sharp, C, Malik, A, Gregory, W, Adland, E, Jooste, P, Simmonds, P, Klenerman, P, Goulder, P